1. O2‐13‐04: Early Clinical Results and Preclinical Validation of the O‐Glcnacase (OGA) Inhibitor Mk‐8719 as a Novel Therapeutic for the Treatment of Tauopathies. (1st July 2016) Authors: Smith, Sean M.; Struyk, Arie; Jonathan, Daniel; Declercq, Ruben; Marcus, Jacob; Toolan, Dawn; Wang, Xiaohai; Schachter, Joel B.; Cosden, Mali; Pearson, Michelle; Hess, Fred; Selnick, Harold; Salinas, Cristian; Li, Wenping; Duffy, Joseph; McEachern, Ernest; Vocadlo, David; Renger, John J.; Eric, H... Journal: Alzheimer's & dementia Issue: Volume 12:Supplement 7S(2016)Part 5 Page Start: P261 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P3‐066: A Cellular Expression Model of TAU Hyperphosphorylation and Aggregation That does not Utilize Frontotemporal Dementia Mutations. (1st July 2016) Authors: Schachter, Joel B.; Cosden, Mali; Meteer, Jeffrey; Majercak, John; Hess, Fred; Niroomand, Shahriar; Renger, John J.; Winrow, Christopher J. Journal: Alzheimer's & dementia Issue: Volume 12:Supplement 7S(2016)Part 17 Page Start: P842 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P3‐073: Intervention of TAU Pathology Prevents Behavioral Changes in RTG4510 Mouse Model of Tauopathy. (1st July 2016) Authors: Wang, Xiaohai; Smith, Karen; Pearson, Michelle; Hughes, Anna; Cosden, Mali; Marcus, Jacob; Hess, Fred; Savage, Mary; Renger, John J.; Rosahl, Thomas W.; Smith, Sean M.; Schachter, Joel B.; Uslaner, Jason M. Journal: Alzheimer's & dementia Issue: Volume 12:Supplement 7S(2016)Part 17 Page Start: P845 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗